Jascayd and dosage: Strengths, form, when to take, and more
Jascayd comes as an oral tablet. It’s usually taken twice per day.
The active ingredient in Jascayd is nerandomilast. Jascayd belongs to a group of drugs called phosphodiesterase 4
(PDE4) inhibitor.
This article describes the dosage of Jascayd, as well as its strengths and how to take it.
Your doctor will prescribe the dosage that’s right for you. In some cases, doctors may adjust your dosage from those shown here.
Jascayd is approved to treat idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. The typical Jascayd dosage for adults with these conditions is 18 mg, taken twice daily, about 12 hours apart.
Always follow your prescribing doctor’s instructions. Notify them if you experience any side effects that may prevent you from taking your medication.
Your doctor may prescribe Jascayd in combination with another drug called pirfenidone (Esbriet).
Your doctor or pharmacist will advise you how to take Jascayd. Typically, recommendations for taking Jascayd include:
Jascayd is usually a long-term treatment. If you and your doctor determine that it’s safe and effective for your condition, you’ll likely take it long term.
Do not take more Jascayd than your doctor prescribes, as this can lead to harmful effects.
Call your doctor right away if you think you’ve taken too much Jascayd. You can also call 800-222-1222 to reach Poison Help or use its online resource. But if you have severe symptoms, immediately call 911 (or your local emergency number) or go to the nearest emergency room.
Disclaimer: While Medical News Today strives for factual, comprehensive, and current information, this article is not a substitute for a licensed healthcare professional’s expertise. Always consult a doctor before taking or discontinuing any medication. Drug information is subject to change and may not cover all uses, directions, precautions, warnings, interactions, reactions, or adverse effects. The lack of a warning does not guarantee a drug’s safety, effectiveness, or appropriateness for all patients or specific uses. Learn more about our approach to content integrity.